Dr. DasGupta graduated with a double Bachelor’s degree, in Chemistry (B.Sc. Hons., University of Delhi, India, 1994), and in Genetics (B.A., Cambridge University, UK, 1996). He obtained his Ph. D. in Developmental Biology and Molecular Medicine from the University of Chicago, 2002. Thereafter, Dr. DasGupta moved to the Harvard Medical School, Boston to conduct his postdoctoral research where he pioneered whole genome high-throughput functional screens to identify novel regulators of cell-signalling pathways using RNAi technology. Between 2005-2014 Dr. DasGupta established his own research program at the NYU-Cancer Institute, where he rose to the rank of Associate Professor. In 2014, Dr. DasGupta moved to the Genome Institute of Singapore (GIS) where currently he serves as a Senior Group Leader and leads the program in Precision Oncology and Cancer Evolution. The major focus of his program is to define the mechanistic basis for spatio-temporal cross-regulatory interactions between tumor cells and their microenvironment (TME), that drive cellular plasticity and intra-tumor phenotypic heterogeneity, both during tumorigenesis and tumor progression to treatment resistant, metastatic disease.